Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP553466.RAxsf8xNTb__WRb9e2tSOzGioTq51Ecamq7-44-QMXhtY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP553466.RAxsf8xNTb__WRb9e2tSOzGioTq51Ecamq7-44-QMXhtY130_assertion type Assertion NP553466.RAxsf8xNTb__WRb9e2tSOzGioTq51Ecamq7-44-QMXhtY130_head.
- NP553466.RAxsf8xNTb__WRb9e2tSOzGioTq51Ecamq7-44-QMXhtY130_assertion description "[To date, two high-penetrance melanoma susceptibility genes, cyclin-dependent kinas inhibitor (CDKN)2A on chromosome 9p21 and cyclin-dependent kinase (CDK4) on 12q13, have been identified.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP553466.RAxsf8xNTb__WRb9e2tSOzGioTq51Ecamq7-44-QMXhtY130_provenance.
- NP553466.RAxsf8xNTb__WRb9e2tSOzGioTq51Ecamq7-44-QMXhtY130_assertion evidence source_evidence_literature NP553466.RAxsf8xNTb__WRb9e2tSOzGioTq51Ecamq7-44-QMXhtY130_provenance.
- NP553466.RAxsf8xNTb__WRb9e2tSOzGioTq51Ecamq7-44-QMXhtY130_assertion SIO_000772 16759158 NP553466.RAxsf8xNTb__WRb9e2tSOzGioTq51Ecamq7-44-QMXhtY130_provenance.
- NP553466.RAxsf8xNTb__WRb9e2tSOzGioTq51Ecamq7-44-QMXhtY130_assertion wasDerivedFrom befree-2016 NP553466.RAxsf8xNTb__WRb9e2tSOzGioTq51Ecamq7-44-QMXhtY130_provenance.
- NP553466.RAxsf8xNTb__WRb9e2tSOzGioTq51Ecamq7-44-QMXhtY130_assertion wasGeneratedBy ECO_0000203 NP553466.RAxsf8xNTb__WRb9e2tSOzGioTq51Ecamq7-44-QMXhtY130_provenance.